II
AVEO

Inspire Investing’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Inspire Investing’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-79
Closed – – 802
2020
Q1 		$0 Buy
+79
New +$392 ﹤0.01% 833
2018
Q1 		– Sell
-34
Closed -$1K – 843
2017
Q4 		$1K Buy
+34
New +$1.06K ﹤0.01% 907

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Inspire Investing's AVEO Position: Q2 2020 in Review

Inspire Investing sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2020, closing a stake of 79 shares.

Inspire Investing first reported a position in AVEO in Q4 2017 and held it in 2 quarters. The position peaked at $1K in Q4 2017. 65 funds tracked by Wall St. Rank hold AVEO as of Q2 2020.

  • Inspire Investing reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2020 after selling out during the quarter.
  • Inspire Investing sold 79 AVEO Pharmaceuticals, Inc. shares in Q2 2020.
  • Inspire Investing first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2017 and held it in 2 quarters.
  • Inspire Investing's AVEO Pharmaceuticals, Inc. position peaked at $1K in Q4 2017.
  • 65 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2020.

Based on Inspire Investing's 13F filing for Q2 2020, filed 12 Aug 2020.